Krishna Institute of Medical Sciences Limited
KIMS · Hospitals · NSE
₹770
Current Market Price
Under Review— We don’t have enough data to publish a fair value estimate for KIMS yet. Reason: Data Limited.
Updated 2h ago
YieldIQ Score
—
Piotroski F-Score
5/9
Economic Moat
Narrow
Confidence
20%
ROE
10.7%
Debt/Equity
1.89
WACC
9.5%
Market Cap
₹30,811 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
12.6%
Return on capital employed
EV / EBITDA
40.6×
Enterprise multiple
Debt / EBITDA
3.9×
Leverage vs earnings
Interest Coverage
7.3×
EBIT covers interest
Current Ratio
0.83×
Short-term liquidity
Asset Turnover
—
Revenue per ₹ of assets
Revenue CAGR (3Y)
13.3%
3-year revenue growth
Revenue CAGR (5Y)
16.8%
5-year revenue growth
Ratio Trends
KIMS · last 6 annual periods
ROE
10.7%
ROCE
12.6%
Operating Margin
—
Debt / Equity
1.89×
PE
33.3×
EV / EBITDA
18.4×
Historical Financials
KIMS · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹1651 Cr | ₹2168 Cr | ₹2474 Cr | ₹3035 Cr | ₹3905 Cr | +24.0% |
| EBITDA | ₹546 Cr | ₹643 Cr | ₹652 Cr | ₹826 Cr | ₹820 Cr | +10.7% |
| EBIT | ₹463 Cr | ₹515 Cr | ₹507 Cr | — | — | +2.3% |
| PAT | ₹333 Cr | ₹336 Cr | ₹310 Cr | ₹385 Cr | ₹241 Cr | -7.7% |
| EPS (diluted) | ₹41.88 | ₹42.03 | ₹38.75 | — | — | -1.9% |
| CFO | ₹324 Cr | ₹432 Cr | ₹521 Cr | ₹582 Cr | ₹511 Cr | +12.1% |
| CapEx | ₹-170 Cr | ₹-575 Cr | ₹-647 Cr | ₹-1009 Cr | ₹-1428 Cr | — |
| FCF | ₹154 Cr | ₹-142 Cr | ₹-126 Cr | ₹-427 Cr | ₹-917 Cr | — |
| Total Assets | ₹1907 Cr | ₹2941 Cr | ₹3852 Cr | ₹5736 Cr | ₹7759 Cr | +42.0% |
| Total Debt | ₹257 Cr | ₹678 Cr | ₹1356 Cr | ₹2557 Cr | ₹4253 Cr | +101.8% |
| Shareholders' Equity | ₹1387 Cr | ₹1670 Cr | ₹1828 Cr | ₹2138 Cr | ₹2247 Cr | +12.8% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
KIMS vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 MEDANTA Global Health Limited | -74.4% | 40 | Data Limited | 14.1% | — |
 ASTERDM ASTERDM | — | — | Pending | 156.9% | — |
 NH Narayana Hrudayalaya Ltd. | -57.0% | 35 | Above Fair Value | 17.8% | — |
 FORTIS Fortis Healthcare Limited | -58.9% | 40 | Above Fair Value | 10.5% | 57.6× |
 MAXHEALTH MAXHEALTH | — | — | Pending | 13.4% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for KIMS in the last 10 years.
Risk Analysis
Volatility & drawdown
Risk profile of KIMS →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for KIMS →
Compare
Head-to-head with peers
Compare KIMS side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse KIMSNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.